丸激素恢复对高风险局部性前列腺癌瘤结果的影响
Trevor C Hunt1, Kamil Malshy1, Matthew Steidle1
1Department of Urology, University of Rochester Medical Center, Rochester, New York, USA.
The Prostate
|September 10, 2025
概括
在雄激素剥夺疗法 (ADT) 后的恢复没有影响接受激进前列腺切除术的高风险前列腺癌 (HRPCa) 的男性的生存结果. 这一发现表明HRPCa患者的治疗策略具有灵活性.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 内分泌学 在内分泌学.
背景情况:
- 前列腺癌 (PCa) 对雄激素敏感,导致雄激素剥夺疗法 (ADT).
- 高风险的PCa (HRPCa) 结果比低风险疾病更糟糕.
- 在放射治疗患者中,ADT后的丸激素恢复影响了结果,但在手术管理的HRPCa中并非如此.
研究的目的:
- 调查恢复与HRPCa癌症结局之间的关联,这些患者接受了激进前列腺切除术 (RP) 和ADT治疗.
- 探索的恢复速度是否会影响结果.
主要方法:
- 两项III期临床试验 (CALGB 90203和SWOG S9921) 的数据汇总后期分析.
- 包括445名HRPCa患者,接受ADT和RP治疗.
- 根据预先定义的门,将患者分为丸激素恢复或未恢复的组;分析早期与晚期恢复.
主要成果:
- 87.2%的患者实现了丸激素的恢复.
- 在康复和未康复组之间,整体存活率 (OS) 或修改无事件存活率 (mEFS) 没有显著差异.
- 在分析每项试验数据或根据恢复速度 (早期与晚期) 观察到没有显著差异.
结论:
- 的恢复状态和速度与HRPCa患者在RP和ADT后的瘤结局没有显著关联.
- 这些发现支持对治疗策略的进一步研究,如HRPCa间歇性ADT.
- 结果可能有助于优化生活质量,同时保持癌症疗效.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:20Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
01:21Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:26Testosterone: Functions and Regulation
2.0K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.0K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K